Molecular characterization and localization of Plasmodium falciparum choline kinase

Biochimica et Biophysica Acta - General Subjects

Volumn 1760, Issue 7, 2006, Pages 1027-1038

  Choubey, Vinay ^a   Guha, Mithu ^a   Maity, Pallab ^a   Kumar, Sanjay ^a   Raghunandan, Resmi ^a   Maulik, Prakas R ^a   Mitra, Kalyan ^a   Halder, Umesh C ^b   Bandyopadhyay, Uday ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b JADAVPUR UNIVERSITY   (India)

Author keywords

Choline kinase; Cloning; Phosphocholine; Plasmodium falciparum; Protein characterization

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHOLINE; CHOLINE KINASE; ENZYME INHIBITOR; ETHANOLAMINE; PHOSPHORYLCHOLINE; RECOMBINANT PROTEIN;

ANTIMALARIAL ACTIVITY; ARTICLE; CAENORHABDITIS ELEGANS; CATALYSIS; CHROMOSOME 14; CIRCULAR DICHROISM; CONFOCAL MICROSCOPY; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; GENOME; MICROBIAL GROWTH; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE DATABASE; SEQUENCE HOMOLOGY; SOUTHERN BLOTTING; STRUCTURAL HOMOLOGY; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; ANIMALS; CAENORHABDITIS ELEGANS; CHOLINE KINASE; ERYTHROCYTES; HUMANS; KINETICS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHOSPHORYLCHOLINE; PLASMODIUM FALCIPARUM; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID;

CAENORHABDITIS ELEGANS; PLASMODIUM FALCIPARUM;

EID: 33745102710     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2006.03.003     Document Type: Article

References (73)

1. Breman J.G. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am. J. Trop. Med. Hyg. 64 (2001) 1-11
2. WHO Expert Committee on Malaria, World Health Organ Tech Rep Ser 892 (2000) i-v, 1-74.
3. Sachs J., and Malaney P. The economic and social burden of malaria. Nature 415 (2002) 680-685
4. White N.J. Antimalarial drug resistance. J. Clin. Invest. 113 (2004) 1084-1092
5. Exton J.H. Phosphatidylcholine breakdown and signal transduction. Biochim. Biophys. Acta 1212 (1994) 26-42
6. Billah M.M., and Anthes J.C. The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem. J. 269 (1990) 281-291
7. Kiss Z. Effects of phorbol ester on phospholipid metabolism. Prog. Lipid Res. 29 (1990) 141-166
8. Holz Jr. G.G. Lipids and the malarial parasite. Bull. World Health Organ. 55 (1977) 237-248
9. Vial H.J., and Ancelin M.L. In: Sherman (Ed). Malaria: Parasite Biology, Pathogenesis, and Protection (1998), ASM Press, Washington, DC 159-175
10. Ancelin M.L., Parant M., Thuet M.J., Philippot J.R., and Vial H.J. Increased permeability to choline in simian erythrocytes after Plasmodium knowlesi infection. Biochem. J. 273 Pt. 3 (1991) 701-709
11. Kirk K. Membrane transport in the malaria-infected erythrocyte. Physiol. Rev. 81 (2001) 495-537
12. Biagini G.A., Pasini E.M., Hughes R., De Koning H.P., Vial H.J., O'Neill P.M., Ward S.A., and Bray P.G. Characterization of the choline carrier of Plasmodium falciparum: a route for the selective delivery of novel antimalarial drugs. Blood 104 (2004) 3372-3377
13. Lehane A.M., Saliba K.J., Allen R.J., and Kirk K. Choline uptake into the malaria parasite is energized by the membrane potential. Biochem. Biophys. Res. Commun. 320 (2004) 311-317
14. Ancelin M.L., and Vial H.J. Regulation of phosphatidylcholine biosynthesis in Plasmodium-infected erythrocytes. Biochim. Biophys. Acta 1001 (1989) 82-89
15. Yeo H.J., Sri J., Widada O., and Mercereau-Puijalon H.J. Molecular cloning of CTP: phosphocholine cytidylyltransferase from Plasmodium falciparum. Eur. J. Biochem. 233 (1995) 62-72
16. Yeo H.J., Larvor M.P., Ancelin M.L., and Vial H.J. Plasmodium falciparum CTP:phosphocholine cytidylyltransferase expressed in Escherichia coli: purification, characterization and lipid regulation. Biochem. J. 324 Pt. 3 (1997) 903-910
17. Larvor M.P., Cerdan R., Gumila C., Maurin L., Seta P., Roustan C., and Vial H. Characterization of the lipid-binding domain of the Plasmodium falciparum CTP:phosphocholine cytidylyltransferase through synthetic-peptide studies. Biochem. J. 375 (2003) 653-661
18. Pessi G., Kociubinski G., and Mamoun C.B. A pathway for phosphatidylcholine biosynthesis in Plasmodium falciparum involving phosphoethanolamine methylation. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 6206-6211
19. Pessi G., Choi J.Y., Reynolds J.M., Voelker D.R., and Mamoun C.B. In vivo evidence for the specificity of Plasmodium falciparum phosphoethanolamine methyltransferase and its coupling to the Kennedy pathway. J. Biol. Chem. 280 (2005) 12461-12466
20. Ancelin M.L., Vial H.J., and Philippot J.R. Inhibitors of choline transport into Plasmodium-infected erythrocytes are effective antiplasmodial compounds in vitro. Biochem. Pharmacol. 34 (1985) 4068-4071
21. Ancelin M.L., and Vial H.J. Quaternary ammonium compounds efficiently inhibit Plasmodium falciparum growth in vitro by impairment of choline transport. Antimicrob. Agents Chemother. 29 (1986) 814-820
22. Ancelin M.L., Calas M., Bompart J., Cordina G., Martin D., Ben Bari M., Jei T., Druilhe P., and Vial H.J. Antimalarial activity of 77 phospholipid polar head analogs: close correlation between inhibition of phospholipid metabolism and in vitro Plasmodium falciparum growth. Blood 91 (1998) 1426-1437
23. Wengelnik K., Vidal V., Ancelin M.L., Cathiard A.M., Morgat J.L., Kocken C.H., Calas M., Herrera S., Thomas A.W., and Vial H.J. A class of potent antimalarials and their specific accumulation in infected erythrocytes. Science 295 (2002) 1311-1314
24. Roggero R., Zufferey R., Minca M., Richier E., Calas M., Vial H., and Ben Mamoun C. Unraveling the mode of action of the antimalarial choline analog G25 in Plasmodium falciparum and Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 48 (2004) 2816-2824
25. Vial H.J., Wein S., Farenc C., Kocken C., Nicolas O., Ancelin M.L., Bressolle F., Thomas A., and Calas M. Prodrugs of bisthiazolium salts are orally potent antimalarials. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 15458-15463
26. Van Deenen L.L.M., and De Gier J. The Red Blood Cell (1975), Academic Press, New York
27. Yu Y., Sreenivas A., Ostrander D.B., and Carman G.M. Phosphorylation of Saccharomyces cerevisiae choline kinase on Ser30 and Ser85 by protein kinase A regulates phosphatidylcholine synthesis by the CDP-choline pathway. J. Biol. Chem. 277 (2002) 34978-34986
28. Tasseva G., Richard L., and Zachowski A. Regulation of phosphatidylcholine biosynthesis under salt stress involves choline kinases in Arabidopsis thaliana. FEBS Lett. 566 (2004) 115-120
29. Warden C.H., and Friedkin M. Regulation of choline kinase activity and phosphatidylcholine biosynthesis by mitogenic growth factors in 3T3 fibroblasts. J. Biol. Chem. 260 (1985) 6006-6011
30. Ancelin M.L., and Vial H.J. Choline kinase activity in Plasmodium-infected erythrocytes: characterization and utilization as a parasite-specific marker in malarial fractionation studies. Biochim. Biophys. Acta 875 (1986) 52-58
31. de Molina A.R., Banez-Coronel M., Gutierrez R., Rodriguez-Gonzalez A., Olmeda D., Megias D., and Lacal J.C. Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression. Cancer Res. 64 (2004) 6732-6739
32. Chung T., Huang J.S., Mukherjee J.J., Crilly K.S., and Kiss Z. Expression of human choline kinase in NIH 3T3 fibroblasts increases the mitogenic potential of insulin and insulin-like growth factor I. Cell. Signal. 12 (2000) 279-288
33. Cuadrado A., Carnero A., Dolfi F., Jimenez B., and Lacal J.C. Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors. Oncogene 8 (1993) 2959-2968
34. Hernandez-Alcoceba R., Saniger L., Campos J., Nunez M.C., Khaless F., Gallo M.A., Espinosa A., and Lacal J.C. Choline kinase inhibitors as a novel approach for antiproliferative drug design. Oncogene 15 (1997) 2289-2301
35. Ramirez de Molina A., Gutierrez R., Ramos M.A., Silva J.M., Silva J., Bonilla F., Sanchez J.J., and Lacal J.C. Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy. Oncogene 21 (2002) 4317-4322
36. Rodriguez-Gonzalez A., Ramirez de Molina A., Fernandez F., and Lacal J.C. Choline kinase inhibition induces the increase in ceramides resulting in a highly specific and selective cytotoxic antitumoral strategy as a potential mechanism of action. Oncogene 23 (2004) 8247-8259
37. Rodriguez-Gonzalez A., Ramirez de Molina A., Banez-Coronel M., Megias D., and Lacal J.C. Inhibition of choline kinase renders a highly selective cytotoxic effect in tumour cells through a mitochondrial independent mechanism. Int. J. Oncol. 26 (2005) 999-1008
38. Wieder T., Orfanos C.E., and Geilen C.C. Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine. J. Biol. Chem. 273 (1998) 11025-11031
39. Pankova-Kholmyansky I., Dagan A., Gold D., Zaslavsky Z., Skutelsky E., Gatt S., and Flescher E. Ceramide mediates growth inhibition of the Plasmodium falciparum parasite. Cell. Mol. Life Sci. 60 (2003) 577-587
40. Ancelin M.L., and Vial H.J. Several lines of evidence demonstrating that Plasmodium falciparum, a parasitic organism, has distinct enzymes for the phosphorylation of choline and ethanolamine. FEBS Lett. 202 (1986) 217-223
41. Trager W., and Jensen J.B. Human malaria parasites in continuous culture. Science 193 (1976) 673-675
42. Wallach M. Efficient extraction and translation of Plasmodium falciparum messenger RNA. Mol. Biochem. Parasitol. 6 (1982) 335-342
43. Sambrook J., Fritsch E.E., and Maniatis T. Molecular Cloning: A Laboratory Manual. Second ed. (1989), Cold Spring Harbor Lab. Press, Plainview, NY
44. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
45. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
46. Cook S.J., and Wakelam M.J. Analysis of the water-soluble products of phosphatidylcholine breakdown by ion-exchange chromatography. Bombesin and TPA (12-O-tetradecanoylphorbol 13-acetate) stimulate choline generation in Swiss 3T3 cells by a common mechanism. Biochem. J. 263 (1989) 581-587
47. Uchida T., and Yamashita S. Purification and properties of choline kinase from rat brain. Biochim. Biophys. Acta 1043 (1990) 281-288
48. Bandyopadhyay U., Bhattacharyya D.K., Chatterjee R., and Banerjee R.K. Localization of gastric peroxidase and its inhibition by mercaptomethylimidazole, an inducer of gastric acid secretion. Biochem. J. 284 Pt. 2 (1992) 305-312
49. Chaubey S., Kumar A., Singh D., and Habib S. The apicoplast of Plasmodium falciparum is translationally active. Mol. Microbiol. 56 (2005) 81-89
50. Fiser A., Do R.K., and Sali A. Modeling of loops in protein structures. Protein Sci. 9 (2000) 1753-1773
51. Marti-Renom M.A., Stuart A.C., Fiser A., Sanchez R., Melo F., and Sali A. Comparative protein structure modeling of genes and genomes. Annu. Rev. Biophys. Biomol. Struct. 29 (2000) 291-325
52. Sali A., and Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234 (1993) 779-815
53. Oyedotun K.S., and Lemire B.D. The quaternary structure of the Saccharomyces cerevisiae succinate dehydrogenase. Homology modeling, cofactor docking, and molecular dynamics simulation studies. J. Biol. Chem. 279 (2004) 9424-9431
54. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22 (1994) 4673-4680
55. Laskowski R.A., MacArthur M.W., Moss D.S., and Thronton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26 (1993) 283-291
56. Morris A.L., MacArthur M.W., Hutchinson E.G., and Thornton J.M. Stereochemical quality of protein structure coordinates. Proteins 12 (1992) 345-364
57. Johnson W.C. Analyzing protein circular dichroism spectra for accurate secondary structures. Proteins 35 (1999) 307-312
58. Brenner S. Phosphotransferase sequence homology. Nature 329 (1987) 21
59. Zheng J., Knighton D.R., ten Eyck L.F., Karlsson R., Xuong N., Taylor S.S., and Sowadski J.M. Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor. Biochemistry 32 (1993) 2154-2161
60. Hon W.C., McKay G.A., Thompson P.R., Sweet R.M., Yang D.S., Wright G.D., and Berghuis A.M. Structure of an enzyme required for aminoglycoside antibiotic resistance reveals homology to eukaryotic protein kinases. Cell 89 (1997) 887-895
61. Ishidate K., Furusawa K., and Nakazawa Y. Complete co-purification of choline kinase and ethanolamine kinase from rat kidney and immunological evidence for both kinase activities residing on the same enzyme protein(s) in rat tissues. Biochim. Biophys. Acta 836 (1985) 119-124
62. Porter T.J., and Kent C. Purification and characterization of choline/ethanolamine kinase from rat liver. J. Biol. Chem. 265 (1990) 414-422
63. Peisach D., Gee P., Kent C., and Xu Z. The crystal structure of choline kinase reveals a eukaryotic protein kinase fold. Structure (Camb) 11 (2003) 703-713
64. Yuan C., and Kent C. Identification of critical residues of choline kinase A2 from Caenorhabditis elegans. J. Biol. Chem. 279 (2004) 17801-17809
65. Edsall J.T., Flory P.J., Kendrew J.C., Liquori A.M., Nemethy G., Ramachandran G.N., and Scheraga H.A. A proposal of standard conventions and nomenclature for the description of polypeptide conformations. J. Mol. Biol. 15 (1966) 399-407
66. Gee P., and Kent C. Multiple isoforms of choline kinase from Caenorhabditis elegans: cloning, expression, purification, and characterization. Biochim. Biophys. Acta 1648 (2003) 33-42
67. Aoyama C., Liao H., and Ishidate K. Structure and function of choline kinase isoforms in mammalian cells. Prog. Lipid Res. 43 (2004) 266-281
68. Kim K.H., Voelker D.R., Flocco M.T., and Carman G.M. Expression, purification, and characterization of choline kinase, product of the CKI gene from Saccharomyces cerevisiae. J. Biol. Chem. 273 (1998) 6844-6852
69. Brostrom M.A., and Browning E.T. Choline kinase from brewers' yeast. Partial purification, properties, and kinetic mechanism. J. Biol. Chem. 248 (1973) 2364-2371
70. Monks D.E., Goode J.H., and Dewey R.E. Characterization of soybean choline kinase cDNAs and their expression in yeast and Escherichia coli. Plant Physiol. 110 (1996) 1197-1205
71. Tanaka K., Tolbert N.E., and Gohlke A.F. Choline kinase and phosphorylcholine phosphatase in plants. Plant Physiol. 41 (1966) 307-312
72. Hosaka K., Tanaka S., Nikawa J., and Yamashita S. Cloning of a human choline kinase cDNA by complementation of the yeast cki mutation. FEBS Lett. 304 (1992) 229-232
73. Vial H.J., and Calas M. In: Rosenthal P. (Ed). Antimalarial chemotherapy, mechanisms of action, modes of resistance, and new directions in drug development (2001), Humana Press, Totowa, NJ 347-365